Douglas Corley to Neoplasms
This is a "connection" page, showing publications Douglas Corley has written about Neoplasms.
Connection Strength
1.444
-
Promises and Potential Pitfalls of Shared Decision Making in Cancer Screening. Gastroenterology. 2020 03; 158(4):802-805.
Score: 0.485
-
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1517-1520.
Score: 0.146
-
Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021 10; 151:106595.
Score: 0.135
-
Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
Score: 0.128
-
Incidence rates of cardiovascular outcomes in a community-based population of cancer patients. Cancer Med. 2019 12; 8(18):7913-7923.
Score: 0.120
-
Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network. JCO Clin Cancer Inform. 2019 09; 3:1-10.
Score: 0.119
-
Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin. 2018 05; 68(3):199-216.
Score: 0.108
-
Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors. Aliment Pharmacol Ther. 2016 Jan; 43(1):73-82.
Score: 0.091
-
Most common 'sporadic' cancers have a significant germline genetic component. Hum Mol Genet. 2014 Nov 15; 23(22):6112-8.
Score: 0.083
-
Morbidity and Mortality After Surgery for Nonmalignant Colorectal Polyps: A 10-Year Nationwide Analysis. Am J Gastroenterol. 2019 11; 114(11):1802-1810.
Score: 0.030